Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal Oxybutynin in Urge Urinary Incontinence
NCT00749632Phase 2Completed
- Sponsor
- FemmePharma
- Start
- Jul 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxybutynin in urge urinary incontinence (UUI), sponsored by FemmePharma. Started Jul 2007; status: completed.
02
Drugs
oxybutynin
03
Conditions
urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT00749632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749632.